Top Story

Algorithm predicts HCC in patients with cirrhosis

April 25, 2015

VIENNA — A new algorithm accurately predicted hepatocellular carcinoma among a cohort of patients with cirrhosis, according to a study presented at the 2015 International Liver Congress.

Simona Bota, MD, PhD, of the Vienna HCC Study Group, Medical University of Vienna, Austria, and colleagues retrospectively collected the data of 940 patients with cirrhosis enrolled at the Medical University of Vienna. Hepatovenous pressure gradient measurements, laboratory parameters and tumor markers were measured among the patients and 680 were included and divided into two groups for the final analysis: training cohort of 379 patients enrolled from 2004-2009 and validation cohort of 301 patients from 2010-2014.

Cover StoryPublication Exclusive

Expansion of ‘Right to Try’ legislation raises ethical, safety concerns

HemOnc Today, April 25, 2015
Early access to experimental drugs has historically been reserved for patients enrolled on clinical trials.In 2009, the FDA revamped its 1980’s expanded access program…
Hemant Murthy, MD In PracticePublication Exclusive

State of the science: High-priority transplant trials for nonmalignant disease

HemOnc Today, April 25, 2015
Hemant Murthy, MD; William Wood, MD
Last June, we launched a series of columns in HemOnc Today intended to discuss high-priority proposals that emerged from the 2014 Blood and Marrow Transplant Clinical…
FDA News

FDA approves Cyramza for mCRC

April 24, 2015
The FDA today announced the approval of ramucirumab for use in combination with FOLFIRI chemotherapy for the treatment of certain patients with metastatic colorectal…
NAFLD-related HCC increasing in US, expected to continue Meeting News Coverage

NAFLD-related HCC increasing in US, expected to continue

April 24, 2015
VIENNA — As non-alcoholic fatty liver disease reaches ‘epidemic’ status, its relation to hepatocellular carcinoma is also on the rise with a higher…
More News Headlines »
CME CNE
Stem Cell Transplant for AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
Meeting News Coverage Video
VIDEO: Immunotherapy developments show 'real promise' in melanoma

VIDEO: Immunotherapy developments show 'real promise' in melanoma

April 16, 2015
Steven J. O’Day, MD, discusses new advancements in immunotherapies and checkpoint inhibitors — such as…
More »
CME
New Advances, New Options: Evaluating the Changing Landscape of Hemophilia

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances…
More »
morganatic-roan
morganatic-roan